Top U.S. cancer centers have launched a federated AI platform, letting models learn from patient data securely to accelerate research and treatment discoveries.

"Cogent’s stock soars on Phase III gastrointestinal cancer data" was originally created and published by Clinical Trials ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, ...

Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed death-ligand 1 (PD-L1)-negative nonsquamous non-small cell lung cancer (NSCLC). In ...

Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information ...

While there's no "good" time to get a cancer diagnosis, it can be particularly devastating to receive it as a younger person.

The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer screening test works.

Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...

The Australian Government today launched the National Cancer Data Framework, marking a major step forward in improving ...

According to data from the National Institute on Minority Health and Health Disparities, Louisiana had the eighth-highest ...

Bowel-related symptoms persist for up to 5 years after colorectal cancer, and higher dietary fiber intake is associated with ...

The Alaska Health Analytics and Vital Records Section (HAVRS), which oversees data from the Alaska Cancer Registry (ACR) and Medical Marijuana Registry that is later shared as needed, has released ...